Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Medical Care May Have Swayed Kevin Durant’s Decision To Join The Nets

What’s worse than losing your patient’s confidence? Probably having it announced throughout national media coverage. This scenario just played out for the medical staff of the Golden State Warriors basketball team as one of the most popular faces within the NBA, Kevin Durant, suffered a season, and possibly career ending Achilles tear injury. Durant’s Achilles…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Medical Care May Have Swayed Kevin Durant’s Decision To Join The Nets

What’s worse than losing your patient’s confidence? Probably having it announced throughout national media coverage. This scenario just played out for the medical staff of the Golden State Warriors basketball team as one of the most popular faces within the NBA, Kevin Durant, suffered a season, and possibly career ending Achilles tear injury.

Durant’s Achilles tear took place in Game 5 of a 7 Game series after he was previously evaluated for a calf strain. It appears that both Durant and head coach, Steve Kerr, “didn’t think he could get injured worse”by returning to play. After feeling mislead or possibly misdiagnosed by the Warriors’ physicians, Durant chose to return to his former foot & ankle surgeon, Dr. Martin O’Malley, MD, at Hospital for Special Surgery in New York, to operate on his ruptured tendon, according to the New York Post. Dr. O’Malley performed surgery on Durant’s broken foot four years ago.

Even worse for the Warriors, the Brooklyn Nets hoped to capitalize on Durant’s lack of confidence in the medical staff to sway Durant to join their squad since Dr. O’Malley is their team foot and ankle specialist. And they succeeded. Kevin Durant confirmed in June that he would be signing a four-year contract with the Brooklyn team.

Why have Durant and the Nets chosen Dr. O’Malley? Well, not only do they have a relationship from a prior injury and surgical repair, but Dr. O’Malley has remained committed to offering the most cutting-edge technology and diagnostics to his patients. One of his most valued tools is the pedCAT, a weight bearing cone beam CT imaging system ,which allows him to perform the scans in his office and review the results with the patients the same day using 3D rendering software. The pedCAT allows him to gather 3D information similar to traditional CT with radiation exposure levels almost equivalent to a standard set of X-Rays.

Watch the video above to hear how Dr. Martin O’Malley, MD, utilizes the pedCAT in his Manhattan orthopedic practice. 

As a patient, wouldn’t you always want your doctor to have more information to help tailor your treatment plan? As a physician, wouldn’t you rather be certain about your diagnosis rather than agonize over equivocal X-Rays? Utilizing software that provides https://curvebeam.com/wp-content/uploads/2016/10/TALAS_curvebeam1.jpga 3D rendering of the patient’s anatomy provides the physician with an opportunity to discuss the nuances of that patient’s case right then and there in the office. It also allows the patient to better understand their treatment options and feel more engaged in the decision-making process. Ultimately, the patient feels that they have greater ownership of their care and assurance that their physician has done all he/she could to get to the true source of the problem.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512